Investor Toolbox
Listen to Call
Recording not yet available.
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
BMY Coverage
Event
Bristol-Myers Squibb Company (BMY) Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial met its primary endpoint, demonstrating clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract (LVOT) gradient at Week 28
Mar 29, 2026
Event
Bristol-Myers Squibb Company (BMY) Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy (xanomeline and trospium chloride)
Mar 28, 2026
Event
Bristol-Myers Squibb Company (BMY) Three New Studies Show Viz.ai’s Cardio Suite Speeds Detection of Cardiac Disease and Improves Patient Follow-Up
Mar 23, 2026
News
BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit
Mar 11, 2026
Transcript
Bristol-Myers Squibb Company (BMY) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Bristol-Myers Squibb Company (BMY) Q3 2025 Earnings Call Transcript
Jan 22, 2026
News
Bristol Myers Squibb (BMY) Earnings: 3Q25 Key Numbers
Oct 30, 2025
News
Bristol Myers Squibb (BMY) Earnings: 2Q25 Key Numbers
Jul 31, 2025